Nippon India Nifty Pharma ETF - Growth Plan vs Aditya Birla Sun Life US Treasury 3-10 Year Bond Etfs Fund of Funds-Direct Plan-Growth
NAV, returns and costs — not a recommendation.
 Nippon India Nifty Pharma ETF - Growth Plan |  Aditya Birla Sun Life US Treasury 3-10 Year Bond Etfs Fund of Funds-Direct Plan-Growth | |
|---|---|---|
| NAV | ₹27.1122 | ₹13.0763 |
| NAV date | 2026-08-18 | 2026-08-18 |
| 1 year | +19.49% | +11.47% |
| 3 year (p.a.) | +20.35% | +9.83% |
| 5 year (p.a.) | +14.55% | +9.83% |
| Expense ratio | 0.18% | 0.17% |
| Fund size | ₹1,622.31 Cr | ₹140.97 Cr |
| Risk | Very high | — |
| Category | Etfs | Fund of Funds Overseas |
Past performance does not guarantee future returns. Mutual fund investments are subject to market risks.